Stomach Cancer
Comprehensive gastric cancer treatment including targeted therapy and immunotherapy.
Overview
Stomach (gastric) cancer requires a multidisciplinary approach combining surgery, chemotherapy, targeted therapy, and immunotherapy. Our team uses HER2 testing and PD-L1 assessment to identify patients who will benefit from the latest targeted and immune-based treatments.
We manage all stages from early resectable disease through advanced metastatic gastric and gastroesophageal junction cancers.
Symptoms & Warning Signs
- Persistent indigestion or heartburn
- Loss of appetite
- Nausea or vomiting
- Abdominal pain or fullness
- Unintended weight loss
- Blood in the stool
Diagnosis & Evaluation
Imaging
CT, PET/CT, and endoscopic ultrasound
Endoscopy & Biopsy
Upper GI endoscopy with tissue sampling
Molecular Testing
HER2, PD-L1, MSI status
Treatment Options
Frequently Asked Questions
What are the risk factors?
H. pylori infection, smoking, high-salt diets, family history, and certain genetic conditions increase risk.
Is immunotherapy used for stomach cancer?
Yes, immunotherapy with checkpoint inhibitors is now part of standard treatment for many advanced gastric cancers, particularly those that are PD-L1 positive or MSI-high.
